Amgen announced that the European Commission (EC) has approved a new indication for Prolia (denosumab) for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult...
Smart Health Innovation Lab, a market adoption accelerator for innovative healthcare technologies, officially opened its state-of-the-art lab in Lancaster, Pa. today, showcasing cutting-edge technologies the lab...
Acelity L.P. Inc., the world’s largest wound care company, and Crawford Healthcare, a rapidly growing UK-based advanced wound care and dermatology company, today announced an agreement...
Astellas has appointed Nahrin Marino to vice president, head of Ethics and Compliance, Americas effective July 15. Previously, Marino served as deputy general counsel, Regulatory for Astellas. She will...
AbbVie, a research-based global biopharmaceutical company, announced the US Food and Drug Administration (FDA) has approved, under priority review, VENCLEXTA (venetoclax tablets) in combination with rituximab...
Professional women in health IT across many European countries believe their contributions go either unnoticed, unappreciated or both. That sentiment is widespread: 93.33 percent of the...
The angiography equipment market is projected to reach USD 13.06 billion by 2023 from USD 10.26 billion in 2018, at a CAGR of 5.0 percent. Market...
In the somewhat consolidated global flow cytometry market, the top three companies accounted for a substantial 50.0 percent in 2016. Their names are Dickinson and Company...
The global non-invasive prenatal testing (NIPT) market is expected to witness solid growth in the forthcoming years. The market’s competitive landscape features fragmentation with the presence...
Agilent Technologies, Inc. announced that it has entered into a definitive agreement to acquire all the business assets of Ultra Scientific, a leading provider of chemical...
Pfizer Inc. announced that the US Food and Drug Administration (FDA) approved XELJANZ (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5...
Central Admixture Pharmacy Services, Inc. (CAPS) will showcase its 503B and 503A compounding services and quality assurance programs at this year’s American Society of Health-Systems Pharmacists...
The global surgical equipment market is envisaged to find a select group of companies exhibiting their dominance over each segment. This could be evidenced with the...
The global mass spectrometry market is expected to be highly fragmented and competitive due to the emergence of various small global and regional vendors. In coming...
The global wound dressing market is expected to exhibit a steady growth in the forthcoming years. The market’s vendor landscape is currently quite dynamic and is...
Copyright © 2026 Medical Buyer maintained by Algocept